Trials / Completed
CompletedNCT01499641
Epidural Steroid Following Discectomy for Herniated Disc Reduces Morbidity
Epidural Steroid Following Discectomy for Herniated Lumbar Disc Reduces Neurological Impairment and Enhances Recovery. A Randomized Study With Two-year Follow-up
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Northern Orthopaedic Division, Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years – 66 Years
- Healthy volunteers
- Not accepted
Summary
Focus of this study is evaluation of the outcome, neurologic impairment and safety of epidural steroide following lumbar discectomy for herniated disc disease.
Detailed description
Methylprednisolone might enhance recovery after discectomy for herniated disc disease without apparent side effect. Convalescence after discectomy for herniated disc disease is dependent on pain and the inflammatory response. In arthroscopic and abdominal surgery steroids reduce the inflammatory response and enhance recovery. 200 patients with herniated disc disease are randomly allocated to receive epidural methylprednisolone 40 mg or none.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylprednisolone | Epidural methylprednisolone 40 mg or none |
Timeline
- Start date
- 2001-05-01
- Primary completion
- 2003-08-01
- Completion
- 2005-12-01
- First posted
- 2011-12-26
- Last updated
- 2014-09-15
Locations
3 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01499641. Inclusion in this directory is not an endorsement.